stratification concepts
longitudinal analysis of ET resistance
different ET resistance mechanisms
patient stratification prior
ET-resistant patients
improved stratification
Breast Cancer Patient Stratification Breast cancer
new concepts
resistance monitoring
MESI-STRAT results
novel ET resistance mechanism-based therapy design
knowledge-based stratification of patients
new computational models
predictive marker panels
marker detection
predictive models
BC accounts
BC metabolism
clinical studies
clinical decision-making
translation of MESI
Metabolite marker panels
patient organization PATH
preclinical models
marker panel development
Networks
targeted therapies
clinical trial cohorts
ineffective therapies
endocrine therapies
EU
unique collection of matched BC tissue
highest cancer-related health-care costs
biological fluids
body fluids
related treatments
Systems Medicine of Metabolic
subgroups
pharmacogenomics
bioinformaticians
serum
network analyses
experimentalists
combination
cost effectiveness
years follow-up
complex disease
surgical interventions
multi-omics data
estrogen receptor-positive
patientsâ€™ quality of life
modelers
high prevalence
industrial partners
medical use
relapse
team of oncologists
recurrence risk assessment
successful validation
tumors
research
diagnostics
SMEs